Income Statement Eurofins Scientific SE

Equities

ERF

FR0014000MR3

Biotechnology & Medical Research

Market Closed - Euronext Paris Other stock markets 16:55:00 05/12/2025 GMT			5-day change	1st Jan Change
58.82 ^EUR	-0.37%		+0.31%	+19.29%

12-02	Eurofins Medical Device Services North America Launches First GMP Pfas Screening and Testing Solutions for Medical Devices	CI
11-05	CAC40 Attempts to Avoid a Seventh Consecutive Decline, Buoyed by Nasdaq Rebound

b1bad7c8e5b86d40fa595b82d42de8._RbC9MCLYW2fjPrpGcBCesE8Ul6Rxz_bMlaUmSLyv1A.zi-sv5rZKirl4MOQXfAuSrNaazDfpHCEfW_Z6hawiyqXRpqyitoiX9PrkQ

Published financial data: EUROFINS SCIENTIFIC SE

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	5.44B	6.72B	6.71B	6.51B	6.95B
Total Revenues	5.44B	6.72B	6.71B	6.51B	6.95B
Cost of Goods Sold, Total	4.03B	4.8B	5.19B	5.14B	5.39B
Gross Profit	1.41B	1.91B	1.53B	1.37B	1.56B
Selling General & Admin Expenses, Total	600K	12.8M	14.2M	13.1M	10.5M
Stock-Based Compensation (IS)	119M	120M	127M	123M	116M
Depreciation & Amortization - (IS)	389M	429M	476M	522M	535M
Other Operating Expenses, Total	508M	562M	618M	658M	662M
Operating Income	904M	1.35B	909M	717M	898M
Interest Expense, Total	-103M	-94.3M	-91.6M	-123M	-146M
Interest And Investment Income	-	-	-	-	-
Net Interest Expenses	-103M	-94.3M	-91.6M	-123M	-146M
Income (Loss) On Equity Invest.	1.7M	2M	900K	400K	1M
Currency Exchange Gains (Loss)	-4.7M	-17.9M	-32.9M	11.2M	4.9M
Other Non Operating Income (Expenses)	500K	1.8M	-11.6M	7.2M	17.1M
EBT, Excl. Unusual Items	799M	1.24B	774M	612M	774M
Restructuring Charges	-53.5M	-32.2M	-	-	-
Merger & Related Restructuring Charges	-6.2M	-13.6M	-8.7M	-15.1M	-24.1M
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) On Sale Of Assets	-	-	141M	-1.8M	-23.6M
Other Unusual Items	-44.9M	-142M	-126M	-172M	-172M
EBT, Incl. Unusual Items	694M	1.06B	780M	423M	555M
Income Tax Expense	154M	274M	174M	116M	149M
Earnings From Continuing Operations	540M	783M	606M	308M	406M
Net Income to Company	540M	783M	606M	308M	406M
Minority Interest	-1M	-400K	4.4M	2.5M	900K
Net Income - (IS)	539M	783M	610M	310M	406M
Preferred Dividend and Other Adjustments	34.1M	34.1M	29.3M	53.7M	50.1M
Net Income to Common Incl Extra Items	505M	748M	581M	256M	356M
Net Income to Common Excl. Extra Items	505M	748M	581M	256M	356M
Per Share Items
Net EPS - Basic	2.71	3.91	3.02	1.33	1.87
Basic EPS - Continuing Operations	2.71	3.91	3.02	1.33	1.87
Basic Weighted Average Shares Outstanding	186M	192M	192M	193M	191M
Net EPS - Diluted	2.58	3.73	2.92	1.3	1.83
Diluted EPS - Continuing Operations	2.58	3.73	2.92	1.3	1.83
Diluted Weighted Average Shares Outstanding	196M	201M	199M	198M	194M
Normalized Basic EPS	2.68	4.06	2.53	2	2.54
Normalized Diluted EPS	2.54	3.87	2.45	1.95	2.49
Dividend Per Share	0.68	1	1	0.5	0.6
Payout Ratio	6.73	21.22	37.36	75.4	36.69
American Depositary Receipts Ratio (ADR)	0.1	0.1	0.1	0.1	0.1
Supplemental Items
EBITDA	1.27B	1.75B	1.35B	1.19B	1.37B
EBITA	1.01B	1.45B	1.01B	816M	992M
EBIT	904M	1.35B	909M	717M	898M
EBITDAR	1.29B	1.76B	1.37B	1.2B	1.37B
Effective Tax Rate - (Ratio)	22.17	25.89	22.33	27.29	26.88
Total Current Taxes	169M	300M	201M	157M	185M
Total Deferred Taxes	-15.4M	-26.3M	-27M	-41.4M	-35.9M
Normalized Net Income	498M	777M	488M	385M	485M
Interest on Long-Term Debt	84.9M	72.7M	76.3M	106M	122M
Non-Cash Pension Expense	-400K	500K	400K	2.2M	2.1M
Supplemental Operating Expense Items
Net Rental Expense, Total	16.8M	12.1M	13.4M	11M	8M
Imputed Operating Lease Interest Expense	4.13M	3.09M	3.23M	2.99M	2.49M
Imputed Operating Lease Depreciation	12.67M	9.01M	10.17M	8.01M	5.51M
Stock-Based Comp., Other (Total)	119M	120M	127M	123M	116M
Total Stock-Based Compensation	119M	120M	127M	123M	116M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	912M	515M	487M	1.22B	614M
Trading Asset Securities, Total	100K	500K	5.6M	4.3M	2M
Total Cash And Short Term Investments	912M	516M	492M	1.23B	616M
Accounts Receivable, Total	1.19B	1.39B	1.34B	1.38B	1.4B
Other Receivables	196M	192M	256M	236M	208M
Total Receivables	1.39B	1.58B	1.6B	1.62B	1.61B
Inventory	157M	154M	146M	139M	142M
Prepaid Expenses	59.6M	68M	78.3M	84.9M	85.7M
Other Current Assets, Total	-	-	-100K	-	-100K
Total Current Assets	2.52B	2.32B	2.31B	3.07B	2.45B
Gross Property Plant And Equipment	3.34B	4.02B	4.74B	4.92B	5.44B
Accumulated Depreciation	-1.77B	-2.19B	-2.57B	-2.62B	-2.88B
Net Property Plant And Equipment	1.57B	1.83B	2.17B	2.3B	2.56B
Long-term Investments	14.1M	81.7M	83.6M	83.6M	117M
Goodwill	3.52B	4.12B	4.52B	4.55B	4.84B
Other Intangibles, Total	825M	896M	919M	796M	788M
Deferred Tax Assets Long-Term	76.6M	90.9M	75.7M	93.8M	130M
Other Long-Term Assets, Total	42.5M	-	-	-	200K
Total Assets	8.58B	9.33B	10.08B	10.89B	10.89B
Liabilities
Accounts Payable, Total	279M	323M	347M	339M	376M
Accrued Expenses, Total	782M	860M	836M	823M	868M
Short-term Borrowings	16.9M	80.3M	78.5M	300K	83.1M
Current Portion of Long-Term Debt	102M	52.8M	6.7M	458M	246M
Current Portion of Leases	119M	121M	129M	143M	150M
Current Income Taxes Payable	84.3M	86M	34.7M	26.7M	35.5M
Unearned Revenue Current, Total	137M	163M	184M	193M	196M
Other Current Liabilities	177M	170M	156M	139M	156M
Total Current Liabilities	1.7B	1.86B	1.77B	2.12B	2.11B
Long-Term Debt	2.5B	2.08B	2.71B	2.89B	2.67B
Long-Term Leases	415M	418M	399M	436M	457M
Pension & Other Post Retirement Benefits	73.3M	75.5M	59.5M	66.2M	66.4M
Deferred Tax Liability Non Current	115M	124M	134M	110M	110M
Other Non Current Liabilities	56.9M	100M	155M	128M	86M
Total Liabilities	4.86B	4.66B	5.23B	5.75B	5.5B
Common Stock, Total	1.9M	1.9M	1.9M	1.9M	1.9M
Retained Earnings	1.31B	1.96B	2.33B	2.39B	2.69B
Treasury Stock	-	-3.6M	-14.2M	-54.9M	-308M
Comprehensive Income and Other	2.38B	2.68B	2.46B	2.74B	2.95B
Total Common Equity	3.69B	4.65B	4.78B	5.08B	5.34B
Minority Interest	26.1M	29.5M	68.9M	59.9M	45.8M
Total Equity	3.72B	4.68B	4.85B	5.14B	5.38B
Total Liabilities And Equity	8.58B	9.33B	10.08B	10.89B	10.89B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	191M	192M	193M	193M	187M
ECS Total Common Shares Outstanding	191M	192M	193M	193M	187M
Book Value / Share	14.1	18.98	21.8	21.14	23.23
Tangible Book Value	-659M	-363M	-661M	-270M	-290M
Tangible Book Value Per Share	-8.69	-7.09	-6.46	-6.58	-6.9
Total Debt	3.15B	2.75B	3.33B	3.93B	3.61B
Net Debt	2.24B	2.24B	2.83B	2.7B	2.99B
Debt Equivalent of Unfunded Proj. Benefit Obligation	73.3M	75.6M	59.5M	66.3M	66.4M
Debt Equivalent Oper. Leases	134M	96.8M	107M	88M	64M
Minority Interest, Total (Incl. Fin. Div)	26.1M	29.5M	68.9M	59.9M	45.8M
Equity Method Investments, Total	5.6M	6.2M	5.2M	5.3M	5.9M
Account Code - Inventory Valuation	5	5	5	5	-
Inventories - Others	182M	193M	174M	157M	157M
Land - (BS)	784M	994M	1.28B	1.45B	-
Machinery, Total	1.58B	1.94B	2.27B	2.38B	4.35B
Full Time Employees	51.52K	57.99K	61.38K	61.8K	62.7K
Accumulated Allowance for Doubtful Accounts (Supple)	44.9M	55.1M	57.9M	63.3M	60.5M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	539M	783M	610M	310M	406M
Depreciation & Amortization - CF	389M	429M	476M	522M	538M
Amortization of Goodwill and Intangible Assets - (CF)	103M	97.6M	104M	99.3M	94.7M
Depreciation & Amortization, Total	492M	526M	580M	621M	633M
Amortization of Deferred Charges, Total - (CF)	4.1M	7.3M	3.8M	4.7M	4.8M
(Gain) Loss From Sale Of Asset	-700K	100K	-141M	1.8M	23.6M
Asset Writedown & Restructuring Costs	36.9M	21.9M	41.7M	72.8M	76M
(Income) Loss On Equity Investments - (CF)	-1.7M	-2M	-900K	-400K	-1M
Stock-Based Compensation (CF)	16.5M	22.2M	22.9M	23.3M	21.8M
Other Operating Activities, Total	186M	157M	-11.7M	49M	111M
Change In Accounts Receivable	-192M	-196M	47.5M	-43.4M	37.2M
Change In Inventories	-77.7M	2.8M	8.6M	11M	3.6M
Change In Accounts Payable	132M	85.6M	20.1M	-41.3M	-25.9M
Change in Unearned Revenues	20.4M	26.3M	21.1M	10.2M	-3M
Change In Deferred Taxes	-6.3M	-6.3M	-7.5M	-	-
Change in Other Net Operating Assets	75.3M	82M	-58.6M	-1.3M	32M
Cash from Operations	1.22B	1.51B	1.14B	1.02B	1.32B
Capital Expenditure	-311M	-458M	-576M	-478M	-454M
Sale of Property, Plant, and Equipment	5.2M	24.8M	14.9M	6.4M	10.2M
Cash Acquisitions	-177M	-533M	-430M	-158M	-343M
Divestitures	-	-	215M	7.3M	-900K
Sale (Purchase) of Intangible assets	-44.7M	-62M	-84.1M	-72M	-74.8M
Investment in Marketable and Equity Securities, Total	-100K	-8.4M	1.5M	1.9M	-3.3M
Other Investing Activities, Total	2.6M	1.6M	2.6M	11.5M	19.3M
Cash from Investing	-525M	-1.03B	-856M	-681M	-846M
Long-Term Debt Issued, Total	946M	826M	634M	638M	118M
Total Debt Issued	946M	826M	634M	638M	118M
Long-Term Debt Repaid, Total	-1.46B	-1.43B	-249M	-270M	-670M
Total Debt Repaid	-1.46B	-1.43B	-249M	-270M	-670M
Issuance of Common Stock	564M	35.8M	14.6M	602M	200K
Repurchase of Common Stock	-	-3.6M	-433M	-238M	-272M
Common Dividends Paid	-36.3M	-166M	-228M	-234M	-149M
Common & Preferred Stock Dividends Paid	-36.3M	-166M	-228M	-234M	-149M
Other Financing Activities, Total	-67.9M	-169M	-49.7M	-83.5M	-117M
Cash from Financing	-48.6M	-910M	-311M	414M	-1.09B
Foreign Exchange Rate Adjustments	-33.9M	39.1M	-800K	-12.7M	9.4M
Miscellaneous Cash Flow Adjustments	-	100K	-100K	100K	-
Net Change in Cash	616M	-396M	-31.8M	738M	-608M
Supplemental Items
Cash Interest Paid	67.8M	169M	49.4M	82.2M	114M
Cash Income Tax Paid (Refund)	94M	297M	296M	140M	161M
Levered Free Cash Flow	793M	866M	501M	512M	811M
Unlevered Free Cash Flow	853M	918M	554M	584M	897M
Change In Net Working Capital	-33.1M	54.3M	61.4M	57.6M	-115M
Net Debt Issued / Repaid	-509M	-607M	385M	368M	-552M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	6.89	9.44	5.85	4.27	5.15
Return on Total Capital	8.49	11.82	7.28	5.2	6.21
Return On Equity %	16.34	18.66	12.72	6.16	7.71
Return on Common Equity	15.48	17.95	12.32	5.2	6.84
Margin Analysis
Gross Profit Margin %	25.97	28.49	22.74	21.1	22.45
SG&A Margin	0.01	0.19	0.21	0.2	0.15
EBITDA Margin %	23.42	26.02	20.15	18.22	19.66
EBITA Margin %	18.52	21.58	15.1	12.53	14.28
EBIT Margin %	16.63	20.13	13.54	11.01	12.92
Income From Continuing Operations Margin %	9.94	11.66	9.03	4.72	5.83
Net Income Margin %	9.92	11.65	9.09	4.76	5.85
Net Avail. For Common Margin %	9.29	11.14	8.65	3.94	5.13
Normalized Net Income Margin	9.16	11.57	7.27	5.91	6.98
Levered Free Cash Flow Margin	14.58	12.89	7.46	7.86	11.66
Unlevered Free Cash Flow Margin	15.69	13.66	8.26	8.97	12.91
Asset Turnover
Asset Turnover	0.66	0.75	0.69	0.62	0.64
Fixed Assets Turnover	3.43	3.95	3.36	2.92	2.86
Receivables Turnover (Average Receivables)	4.96	5.2	4.92	4.79	5
Inventory Turnover (Average Inventory)	34.08	30.87	34.6	36.12	38.38
Short Term Liquidity
Current Ratio	1.48	1.25	1.31	1.45	1.16
Quick Ratio	1.36	1.13	1.18	1.34	1.05
Operating Cash Flow to Current Liabilities	0.72	0.81	0.64	0.48	0.63
Days Sales Outstanding (Average Receivables)	73.85	70.16	74.25	76.26	73.22
Days Outstanding Inventory (Average Inventory)	10.74	11.82	10.55	10.11	9.54
Average Days Payable Outstanding	22.76	22.87	23.63	24.41	24.26
Cash Conversion Cycle (Average Days)	61.83	59.11	61.17	61.95	58.49
Long Term Solvency
Total Debt/Equity	84.89	58.88	68.55	76.43	67.05
Total Debt / Total Capital	45.91	37.06	40.67	43.32	40.14
LT Debt/Equity	78.5	53.46	64.15	64.73	58.15
Long-Term Debt / Total Capital	42.46	33.65	38.06	36.69	34.81
Total Liabilities / Total Assets	56.66	49.88	51.89	52.82	50.55
EBIT / Interest Expense	8.78	14.34	9.92	5.81	6.13
EBITDA / Interest Expense	13.56	19.92	16.26	10.85	10.45
(EBITDA - Capex) / Interest Expense	10.54	15.07	9.97	6.97	7.35
Total Debt / EBITDA	2.26	1.47	2.23	2.93	2.36
Net Debt / EBITDA	1.61	1.19	1.9	2.02	1.96
Total Debt / (EBITDA - Capex)	2.91	1.94	3.64	4.56	3.35
Net Debt / (EBITDA - Capex)	2.07	1.57	3.1	3.14	2.78
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	19.2	23.51	-0.08	-2.94	6.7
Gross Profit, 1 Yr. Growth %	51.77	35.47	-19.74	-9.13	14.41
EBITDA, 1 Yr. Growth %	60.25	37.19	-22.63	-12.23	15.15
EBITA, 1 Yr. Growth %	81.02	43.95	-30.12	-19.43	21.59
EBIT, 1 Yr. Growth %	98.16	49.52	-33.09	-21.1	25.22
Earnings From Cont. Operations, 1 Yr. Growth %	176.84	44.89	-22.63	-49.21	31.78
Net Income, 1 Yr. Growth %	176.33	45.09	-22.03	-49.16	31.01
Normalized Net Income, 1 Yr. Growth %	120.07	55.93	-37.51	-21.03	25.85
Diluted EPS Before Extra, 1 Yr. Growth %	230.77	44.57	-21.72	-55.48	40.77
Accounts Receivable, 1 Yr. Growth %	19.21	16.4	-3.42	2.89	1.45
Inventory, 1 Yr. Growth %	97.98	-1.78	-5.58	-4.53	2.09
Net Property, Plant and Equip., 1 Yr. Growth %	-1.17	16.19	18.46	5.98	11.42
Total Assets, 1 Yr. Growth %	9.62	8.83	8.05	7.98	-0
Tangible Book Value, 1 Yr. Growth %	-60.97	-44.88	82.02	-59.17	7.26
Common Equity, 1 Yr. Growth %	30	25.94	2.89	6.18	5.15
Cash From Operations, 1 Yr. Growth %	80.48	23.4	-24.82	-10.42	29.57
Capital Expenditures, 1 Yr. Growth %	11.72	47.2	29.64	-17.01	-5.12
Levered Free Cash Flow, 1 Yr. Growth %	81.88	9.2	-42.8	2.22	58.34
Unlevered Free Cash Flow, 1 Yr. Growth %	72.73	7.54	-39.94	5.43	53.57
Dividend Per Share, 1 Yr. Growth %	97.1	47.06	0	-50	20
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	19.93	21.34	11.09	-1.52	1.76
Gross Profit, 2 Yr. CAGR %	40.1	43.39	3.94	-14.98	1.55
EBITDA, 2 Yr. CAGR %	34.18	48.28	3.03	-17.59	0.53
EBITA, 2 Yr. CAGR %	40.72	61.43	0.3	-24.97	-1.03
EBIT, 2 Yr. CAGR %	44.89	72.13	0.24	-27.34	-0.6
Earnings From Cont. Operations, 2 Yr. CAGR %	55.5	100.28	5.88	-37.31	-18.19
Net Income, 2 Yr. CAGR %	55.21	100.23	6.36	-37.04	-18.39
Normalized Net Income, 2 Yr. CAGR %	45.23	85.25	-1.06	-29.75	-0.31
Diluted EPS Before Extra, 2 Yr. CAGR %	64.11	118.68	6.39	-40.96	-20.83
Accounts Receivable, 2 Yr. CAGR %	17.47	17.79	6.03	-0.31	2.17
Inventory, 2 Yr. CAGR %	53.77	39.45	-3.7	-5.06	-1.28
Net Property, Plant and Equip., 2 Yr. CAGR %	24.38	7.16	17.32	12.05	8.67
Total Assets, 2 Yr. CAGR %	9.09	9.22	8.44	8.02	3.91
Tangible Book Value, 2 Yr. CAGR %	-37.67	-53.62	0.17	-13.8	-33.83
Common Equity, 2 Yr. CAGR %	17.58	27.96	13.84	4.52	5.66
Cash From Operations, 2 Yr. CAGR %	49.98	49.24	-3.63	-17.93	7.74
Capital Expenditures, 2 Yr. CAGR %	-1.78	28.24	36.15	3.72	-11.27
Levered Free Cash Flow, 2 Yr. CAGR %	97.23	40.93	-20.54	-23.53	27.22
Unlevered Free Cash Flow, 2 Yr. CAGR %	88.01	36.29	-19.41	-20.43	27.24
Dividend Per Share, 2 Yr. CAGR %	53.66	70.25	21.27	-29.29	-22.54
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	22.32	21.12	13.73	6.2	1.14
Gross Profit, 3 Yr. CAGR %	36.4	38.54	17.92	-0.9	-6.38
EBITDA, 3 Yr. CAGR %	32.38	35.18	19.38	-2.33	-7.87
EBITA, 3 Yr. CAGR %	36.97	41.79	22.12	-6.77	-11.87
EBIT, 3 Yr. CAGR %	37.07	46.42	25.8	-7.45	-12.89
Earnings From Cont. Operations, 3 Yr. CAGR %	35.16	51.88	45.86	-17.12	-19.7
Net Income, 3 Yr. CAGR %	35.51	51.76	46.22	-16.84	-19.62
Normalized Net Income, 3 Yr. CAGR %	38.21	48.71	29.15	-8.22	-14.68
Diluted EPS Before Extra, 3 Yr. CAGR %	37.29	57.32	55.27	-20.43	-21.13
Accounts Receivable, 3 Yr. CAGR %	19.14	17.11	10.25	4.97	0.27
Inventory, 3 Yr. CAGR %	44.71	32.43	22.45	-3.98	-2.73
Net Property, Plant and Equip., 3 Yr. CAGR %	31.92	21.59	10.8	13.41	11.84
Total Assets, 3 Yr. CAGR %	13.71	9	8.83	8.29	5.28
Tangible Book Value, 3 Yr. CAGR %	-6.16	-40.17	-26.84	-25.73	-7.28
Common Equity, 3 Yr. CAGR %	14.74	20.3	18.99	11.22	4.73
Cash From Operations, 3 Yr. CAGR %	44.55	40.54	18.79	-5.95	-4.44
Capital Expenditures, 3 Yr. CAGR %	15.7	12.4	27.46	15.44	0.69
Levered Free Cash Flow, 3 Yr. CAGR %	68.03	61.96	4.72	-13.58	-2.54
Unlevered Free Cash Flow, 3 Yr. CAGR %	62.88	56.07	3.91	-11.86	-0.93
Dividend Per Share, 3 Yr. CAGR %	41.5	51.43	42.58	-9.74	-15.66
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	22.77	21.5	17.7	11.49	8.78
Gross Profit, 5 Yr. CAGR %	31.39	31.89	22.35	13.82	10.88
EBITDA, 5 Yr. CAGR %	29.23	29.91	19.75	10.9	11.45
EBITA, 5 Yr. CAGR %	31.41	32.85	20.92	9.92	12.27
EBIT, 5 Yr. CAGR %	31.06	33.47	20.94	10.73	14.49
Earnings From Cont. Operations, 5 Yr. CAGR %	43.08	34.56	22.59	6.6	15.74
Net Income, 5 Yr. CAGR %	43.93	35.08	23	6.74	15.8
Normalized Net Income, 5 Yr. CAGR %	37.02	35.19	20.91	10.27	16.45
Diluted EPS Before Extra, 5 Yr. CAGR %	49.45	35.52	23.98	6.3	18.6
Accounts Receivable, 5 Yr. CAGR %	21.91	21.51	13.71	9.8	6.94
Inventory, 5 Yr. CAGR %	33.15	31.28	22.96	15.92	12.34
Net Property, Plant and Equip., 5 Yr. CAGR %	29.79	29.28	25.87	17.68	9.94
Total Assets, 5 Yr. CAGR %	18.31	17.71	11.57	8.61	6.84
Tangible Book Value, 5 Yr. CAGR %	-3.95	1.31	-3.68	-30.76	-29.72
Common Equity, 5 Yr. CAGR %	30.98	23.35	14.38	13.72	13.47
Cash From Operations, 5 Yr. CAGR %	33.26	32.35	22.91	13.35	14.24
Capital Expenditures, 5 Yr. CAGR %	19.03	24.05	23.48	8.21	10.27
Levered Free Cash Flow, 5 Yr. CAGR %	71.75	45.41	24.54	20.22	13.2
Unlevered Free Cash Flow, 5 Yr. CAGR %	59.23	39.43	22.92	19.34	12.68
Dividend Per Share, 5 Yr. CAGR %	36.22	37.97	33.03	11.66	11.7